RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.

Sodi A, Banfi S, Testa F, Della Corte M, Passerini I, Pelo E, Rossi S, Simonelli F, Italian IRD Working Group

Open source

DOI
10.1186/s13023-021-01868-4
Published
2021 Jun 4
Container
Orphanet journal of rare diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13023-021-01868-4,
  title = {RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.},
  author = {Sodi A and Banfi S and Testa F and Della Corte M and Passerini I and Pelo E and Rossi S and Simonelli F and Italian IRD Working Group},
  year = {2021},
  journal = {Orphanet journal of rare diseases},
  doi = {10.1186/s13023-021-01868-4},
  url = {https://doi.org/10.1186/s13023-021-01868-4}
}

RIS

TY  - JOUR
TI  - RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.
AU  - Sodi A
AU  - Banfi S
AU  - Testa F
AU  - Della Corte M
AU  - Passerini I
AU  - Pelo E
AU  - Rossi S
AU  - Simonelli F
AU  - Italian IRD Working Group
PY  - 2021
JO  - Orphanet journal of rare diseases
DO  - 10.1186/s13023-021-01868-4
UR  - https://doi.org/10.1186/s13023-021-01868-4
ER  - 

APA

A, S., S, B., F, T., M, D. C., I, P., E, P., S, R., F, S., & Group, I. I. W. (2021). RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.. Orphanet journal of rare diseases. https://doi.org/10.1186/s13023-021-01868-4

Source records